一种双机制向的生物对等原药疗法
Qingxin Yao1, Feng Lin2,3, Chenghao Lu2,3
1Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.
Bioconjugate chemistry
|November 13, 2023
概括
这项研究引入了一种新的双机制针对癌症的向治疗,使用生物对等前药. 通过结合两个向策略,它可以增强药物向瘤的输送,提高疗效并减少副作用.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 药物输送系统 药物输送系统
背景情况:
- 生物对等前药疗法提供可控的药物激活,但在瘤向和有效性方面往往面临局限性.
- 目前的单一机制策略与固体瘤异质性作斗争,影响药物和激活剂的输送.
- 需要采用双重向的方法来克服这些局限性并改善治疗结果.
研究的目的:
- 开发一种双机制向的生物对等前药疗法,以提高抗癌疗效和安全性.
- 整合两个正交的,受体独立的瘤向策略,同时提供前药物和激活剂.
- 根据药理动力学优化药物给药序列,以实现空间时间控制的药物激活.
主要方法:
- 利用内源性白素运输系统以*in situ*与白素结合,生物对等中的多克索鲁比前药物形成.
- 采用酶指导自组装 (EISA) 来选择性丰富瘤细胞内的生物对等激活剂.
- 优化了前药物和激活剂的剂量序列,基于它们独特的药理动力学特征.
主要成果:
- 通过专蛋白结合,实现了多克索鲁比辛前药的扩大血循环和选择性瘤积累.
- 通过EISA证明了瘤细胞中生物对等激活剂的特定丰富.
- 通过优化给药序列,实现了时空控制,定位和按需的前药激活.
结论:
- 编排两个离散的,受体独立的向策略,为生物对等的前药疗法提供了一个强大的平台.
- 开发的全小分子系统通过改善药物输送和激活来最大限度地提高治疗效果.
- 这种双重机制的方法显著降低了药物不良反应,提高了化疗剂的安全性.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Principles of Drug Action
6.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


